Thursday, June 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1164 of 1,261

  1. US 6670451

    Netrins

    The Regents of the University of California · Granted Dec 30, 2003 · Expires Dec 25, 2023

    expired

  2. US 6670387

    Thrombopoietin mimetics

    Ligand Pharmaceuticals Incorporated · Granted Dec 30, 2003 · Expires Dec 25, 2023

    expired

  3. HU P0302480

    PYRIDINONE DERIVATIVES FOR TREATMENT OF ATHEROSCLEROSIS, PROCESS FOR PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME

    SMITHKLINE BEECHAM PLC [GB] · Granted Dec 29, 2003 · Expires Dec 24, 2023

    expired

  4. WO 03105839

    VERWENDUNG VON RIBAVIRIN ZUR HERSTELLUNG EINER PHARMAZEUTISCHEN ZUSAMMENSETZUNG GEGEN BUNYAVIRIDAE

    BIOPARTNERS GMBH [CH] · Granted Dec 24, 2003 · Expires Dec 19, 2023

    expired

  5. US 6667034

    METHODS FOR REGULATING THE SPECIFIC LINEAGES OF CELLS PRODUCED IN A HUMAN HEMATOPOIETIC CELL CULTURE, METHODS FOR ASSAYING THE EFFECT OF SUBSTANCES ON LINEAGE-SPECIFIC CELL PRODUCTION, AND CELL COMPOSITIONS PRODUCED BY THESE CULTURES

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Dec 23, 2003 · Expires Dec 18, 2023

    expired

  6. US 6667041

    Use of neurotoxin therapy for treatment of urologic and related disorders

    The Regents of the University of Colorado · Granted Dec 23, 2003 · Expires Dec 18, 2023

    expired

  7. US 6667036

    Methods of treatment using antibodies to P-selectin glycoprotein ligand

    The Board of Regents of the University of Oklahoma · Granted Dec 23, 2003 · Expires Dec 18, 2023

    expired

  8. US 6667313

    8-substituted-6-triflouromethyl-9-pyrido [3,2-G] quinoline compounds as androgen receptor modulators

    Ligand Pharmaceuticals Incorporated · Granted Dec 23, 2003 · Expires Dec 18, 2023

    expired

  9. US 6667152

    Method for selective inactivation of viral replication

    Rigel Pharmaceuticals, Inc. · Granted Dec 23, 2003 · Expires Dec 18, 2023

    expired

  10. US 6667162

    Identification of the gene causing the mouse scurfy phenotype and its human ortholog

    Darwin Discovery Limited · Granted Dec 23, 2003 · Expires Dec 18, 2023

    expired

  11. US 6663858

    In Vivo gene transfer using implanted retroviral producer cells

    The Regents of the University of California · Granted Dec 16, 2003 · Expires Dec 11, 2023

    expired

  12. US 6663857

    In vivo gene transfer using implanted retroviral producer cells

    The Regents of the University of California · Granted Dec 16, 2003 · Expires Dec 11, 2023

    expired

  13. US 6664230

    Orally administered peptides to ameliorate atherosclerosis

    The Regents of the University of California · Granted Dec 16, 2003 · Expires Dec 11, 2023

    expired

  14. US 6664331

    Poly(ethylene glycol) derivatives with proximal reactive groups

    Nektar Therapeutics AL, Corporation · Granted Dec 16, 2003 · Expires Dec 11, 2023

    expired

  15. US 6663886

    Inhibition of cell-cell binding by lipid assemblies

    The Regents of the University of California · Granted Dec 16, 2003 · Expires Dec 11, 2023

    expired

  16. US 6663883

    Matrix adhering to nasal mucosa

    Takeda Chemical Industries Ltd. · Granted Dec 16, 2003 · Expires Dec 11, 2023

    expired

  17. US 6664374

    Polypeptides comprising IL-6 ligand-binding receptor domains

    The United States of America, as represented by the Department of Health and Human Services · Granted Dec 16, 2003 · Expires Dec 11, 2023

    expired

  18. US 6664276

    Benzimidazole compound crystal

    Takeda Chemical Industries Ltd. · Granted Dec 16, 2003 · Expires Dec 11, 2023

    expired

  19. US 6664263

    1,8-naphthalimide imidazo{4,5,1-de}acridones with anti-tumor activity

    The United States of America, as represented by the Department of Health and Human Services · Granted Dec 16, 2003 · Expires Dec 11, 2023

    expired

  20. US 6664227

    Treatment of fibrosis by antagonism of IL-13 and IL-13 receptor chains

    The United States of America, as represented by the Department of Health and Human Services · Granted Dec 16, 2003 · Expires Dec 11, 2023

    expired

  21. US 6664247

    Pyrazole compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Dec 16, 2003 · Expires Dec 11, 2023

    expired

  22. US 6664040

    Compositions and methods for delivery of a molecule into a cell

    The Regents of the University of California · Granted Dec 16, 2003 · Expires Dec 11, 2023

    expired

  23. US 6660731

    Pyrazole compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Dec 9, 2003 · Expires Dec 4, 2023

    expired

  24. US 6660273

    Chimeric vaccine against tick-borne encephalitis virus

    The United States of America, as represented by the Department of Health and Human Services · Granted Dec 9, 2003 · Expires Dec 4, 2023

    expired

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.